News & Events

HTG Molecular Diagnostics Announces Preliminary 2019 Unaudited Financial Results

Preliminary full year 2019 unaudited revenue of $19.2 million Cash and cash equivalents of $33.0 million as of December 31, 2019 TUCSON, Ariz. , Jan. 13, 2020 (GLOBE NEWSWIRE) – HTG Molecular Diagnostics , Inc. (Nasdaq: HTGM) (HTG), a life science company whose mission is to advance precision

full press release

Posted on:

Return To List

Page last updated January 22, 2020